Bamocaftor
Modify Date: 2024-04-04 00:37:07
Bamocaftor structure
|
Common Name | Bamocaftor | ||
|---|---|---|---|---|
| CAS Number | 2204245-48-5 | Molecular Weight | 591.64 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C28H32F3N5O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BamocaftorBamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor can be used combine with Tezacaftor and Ivacaftor in cystic fibrosis research[1]. |
| Name | N-(Phenylsulfonyl)-6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]nicotinamide |
|---|---|
| Synonym | More Synonyms |
| Description | Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore F508del-CFTR protein function. Bamocaftor can be used combine with Tezacaftor and Ivacaftor in cystic fibrosis research[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Bamocaftor is a CFTR corrector designed to restore F508del-CFTR protein function[1]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C28H32F3N5O4S |
| Molecular Weight | 591.64 |
| Exact Mass | 591.212708 |
| LogP | 5.71 |
| Index of Refraction | 1.622 |
| N-(Phenylsulfonyl)-6-(3-{2-[1-(trifluoromethyl)cyclopropyl]ethoxy}-1H-pyrazol-1-yl)-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]nicotinamide |
| 3-Pyridinecarboxamide, N-(phenylsulfonyl)-6-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethyl-1-pyrrolidinyl]- |